Medical Device Vulnerability Response

Receive and scope

Use reliable advisories and manufacturer communications. Match product, model, version, configuration, connectivity, and deployment context to the local inventory.

Coordinate decisions

Bring together the manufacturer, clinical engineering, security, IT, risk, affected clinical operations, and other qualified personnel. Avoid unapproved changes.

Document and verify

Record evidence, decisions, compensating safeguards, deployment status, exceptions, and monitoring. Verify that authorized changes work as intended.

A controlled response workflow

• Intake: record the original advisory, publication date, affected product details, and source.
• Scope: match model, version, configuration, connectivity, location, and workflow against the local inventory.
• Assess: consider credible exploit conditions, clinical and operational consequence, exposure, detectability, and the risk of mitigation.
• Decide: involve manufacturer, clinical engineering, security, IT, safety, affected operations, and other qualified roles.
• Implement and close: authorize, test, deploy, monitor, document exceptions, and verify the inventory and residual risk.

Communicate without creating panic

State which products and versions are affected, what is confirmed locally, what is unknown, which authorized safeguards apply, who owns the next action, and when the assessment will be updated. Avoid translating a vulnerability score directly into patient risk.

Track unresolved exposure

If an update is unavailable or deferred, record compensating safeguards, monitoring, service impact, vendor status, approving role, expiration or trigger, and replacement implications. Unknown inventory fields are response work, not neutral blanks.

FAQ

Common questions